Search - tctmd.com

Displaying 861 - 880 of 915

Sort: Relevancy | Date

Presentation TCT 2016

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses, Robert W. Yeh

October 31, 2016

Presentation TCT 2016

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Presenter: Emmanouil S. Brilakis, Jeffrey W. Moses

October 31, 2016

Presentation TCT 2016

Resources Needed for CHIP

Presenter: Martina Kelly Speight, Michael Guiry

October 30, 2016

Presentation TCT 2016

Edited Taped Cases 2: TBD

Presenter: Martina Kelly Speight, Colin M. Barker

October 30, 2016

Presentation TCT 2016

Edited Taped Cases 1: TBD

Presenter: Martina Kelly Speight, Lauren Morris

October 30, 2016

Presentation TCT 2016

Deep Dive into CHIP (TED Talk): What Is It, and Why Is It Important?

Presenter: Martina Kelly Speight, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2015

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

Presenter: Jeffrey W. Moses, Erick Schampaert, Giuseppe Tarantini

October 14, 2015

Presentation TCT 2015

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Presenter: Jeffrey W. Moses, Erick Schampaert, Nabil Dib

October 14, 2015

Presentation TCT 2015

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Presenter: Jeffrey W. Moses, Erick Schampaert, Gert Richardt

October 14, 2015

Presentation TCT 2015

Atheroablation: Current Technologies and Techniques

Presenter: Jeffrey W. Moses, Erick Schampaert, Mohamed Abdel-Wahab

October 14, 2015

Presentation TCT 2015

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Presenter: Jeffrey W. Moses, Erick Schampaert, Barry D. Rutherford

October 14, 2015

Presentation TCT 2015

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Presenter: Jeffrey W. Moses, Erick Schampaert

October 14, 2015

Presentation TCT 2015

Just How Effective Is Hypothermia in Cardiac Arrest?

Presenter: Tanveer Rab, Holger Thiele, Michel R. Le May

October 14, 2015

Presentation TCT 2015

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Presenter: Tanveer Rab, Holger Thiele

October 14, 2015

Presentation TCT 2015

Escalation Therapies and RV Dysfunction: New Opportunities

Presenter: Tanveer Rab, Holger Thiele, Navin K. Kapur

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Presenter: Tanveer Rab, Holger Thiele, Aly El Banayosy

October 14, 2015

Presentation TCT 2015

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

Presenter: Tanveer Rab, Holger Thiele, Sunil V. Rao

October 14, 2015

Presentation TCT 2015

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

Presenter: Tanveer Rab, Holger Thiele, Jose P.S. Henriques

October 14, 2015

Presentation TCT 2015

The Spectrum of Hemodynamic Support Options for Shock

Presenter: Tanveer Rab, Holger Thiele, Vladimir Dzavik

October 14, 2015

Advertisement

Public Reporting, Appropriateness Criteria, and the CHIP Initiative: At Odds or Working Together?

Introductory Lecture: Defining CHIP/Complex PCI in 2016 - Where We Are and Where We Need to Go

Resources Needed for CHIP

Edited Taped Cases 2: TBD

Edited Taped Cases 1: TBD

Deep Dive into CHIP (TED Talk): What Is It, and Why Is It Important?

New Approaches for Diffuse Disease: DEB, BRS, and Beyond

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Debate: Should Atheroablation Be Used More Often? Yes, Atheroablation Is Underutilized!

Debate: Should Atheroablation Be Used More Often? No, the Present Evidence Says It Should Be Used Sparingly!

Atheroablation: Current Technologies and Techniques

CTO in Patients With Left Main and Multivessel Disease: Why and When to Treat

Sorting Through Revascularization Choices in Left Main and Multivessel Disease: A Practical Approach

Just How Effective Is Hypothermia in Cardiac Arrest?

The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock

Escalation Therapies and RV Dysfunction: New Opportunities

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? ECMO for True Shock!

Debate: What Support Device Should Most Frequently Be Used in Cardiogenic Shock? IABP Is Still Frontline!

What Support Device Should Most Frequently Be Used in Cardiogenic Shock? Impella for Most!

The Spectrum of Hemodynamic Support Options for Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content